PK

Pawan Kumar

Active Director Director DIN 07728820
DIN 07728820 First appointment Feb 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2017
Shareholding value •••• Premium profile

About Pawan Kumar

Data last updated:

Pawan Kumar is a Director at Medvok Pharmaceuticals Private Limited (since 2017). The company operates in Trading. Medvok Pharmaceuticals Private Limited reported revenue of ₹15.1 Lakh (FY 2024).

DIN 07728820
Primary Designation Director
Industry Trading
First Appointment 22 Feb 2017
Oldest Company Age 9 yrs
Largest company Medvok Pharmaceuticals Private Limited · ₹15.1 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Feb 20172017₹15.1 Lakh (FY 2024)Active

Board colleagues of Pawan Kumar

NameDINCompanyDesignation
Jay Shankar Sahu07728824Medvok Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medvok Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Pawan Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pawan Kumar

Pawan Kumar currently holds 1 directorship: Medvok Pharmaceuticals Private Limited (Director, since 22 Feb 2017, revenue ₹15.1 Lakh (FY 2024)).

Pawan Kumar was first appointed on 22 Feb 2017 as Director at Medvok Pharmaceuticals Private Limited.

The current boards of Pawan Kumar's companies include Jay Shankar Sahu (Medvok Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available